Why ADARx Pharmaceuticals, Inc. (ADRX) stock fell 5.8% intraday on Tuesday, November 17, 2026
ADARx Pharmaceuticals, Inc. (ADRX) traded at $13.19 as of 10:31 AM ET, down 5.79% on Tuesday, November 17, 2026, on volume of 276,757 shares (0.4× its 3-month average); market value about $1.50B, according to Nexqual market data (nexqual.com/moves/2026-11-17/ADRX).
ADRX was among the stocks moving 5% or more in an earlier update that day; by the close it was no longer moving that much.
What happened: primary sources
Events Nexqual found for ADRX on Tuesday, November 17, 2026 or the trading day before (November 16, 2026), each linked to its primary source:
- Nov 17, 2026: One of 8 Biotechnology stocks among the day's biggest losers (OMER, PEPG, OVID, CGON, SMMT, RLMD, ADRX, ERAS), with no comparable group among the biggest gainers
These are listed as context. A filing or rating change on the same day is not proof that it caused the move; read the source.
More on ADRX
ADRX stock page: price, SEC financials, insider trades, superinvestor holders, analyst estimates and options. Other big moves that day: November 17, 2026.
Sources: SEC EDGAR, Nexqual Earnings Flash, analyst rating changes, Nexqual market data. Built November 18, 2026 at 20:31 UTC. Not investment advice.
Data source: Nexqual. Last updated: November 18, 2026 at 20:31 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt